OpinionInTandem and the creation of its Vivo Infusion platform, Iconiq is back with its next growth flagshipIconiq goes back to market with a new fund.Chris Witkowsky - 23 March 2022 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in